Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chartwell Injectables is a specialized pharmaceutical company and contract development and manufacturing organization (CDMO) focused on the production of sterile injectable products. Operating out of a significant manufacturing complex in Congers, New York, the company provides comprehensive services including formulation development, analytical testing, and commercial-scale aseptic filling. Their facility, which was formerly owned by Pfizer, is equipped for complex processes such as lyophilization and high-speed vial filling. Chartwell Injectables serves as a critical provider of generic injectable medications, addressing supply chain needs for essential hospital and clinical drugs. As part of the Chartwell Pharmaceuticals group, the company emphasizes quality compliance and reliable delivery of life-saving treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chartwell Injectable.